PD-1 Inhibitor Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of PD-1 Inhibitor Market

1.3 Market Segment by Type

1.3.1 China PD-1 Inhibitor Market Size and Growth Rate of Pembrolizumab from 2016 to 2027

1.3.2 China PD-1 Inhibitor Market Size and Growth Rate of Nivolumab from 2016 to 2027

1.3.3 China PD-1 Inhibitor Market Size and Growth Rate of Atezolizumab from 2016 to 2027

1.3.4 China PD-1 Inhibitor Market Size and Growth Rate of Durvalumab from 2016 to 2027

1.3.5 China PD-1 Inhibitor Market Size and Growth Rate of Avelumab from 2016 to 2027

1.3.6 China PD-1 Inhibitor Market Size and Growth Rate of Other from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China PD-1 Inhibitor Market Size and Growth Rate of Melanoma from 2016 to 2027

1.4.2 China PD-1 Inhibitor Market Size and Growth Rate of Non-small Cell Lung Cancer (NSCLC) from 2016 to 2027

1.4.3 China PD-1 Inhibitor Market Size and Growth Rate of Urothelial Carcinoma from 2016 to 2027

1.4.4 China PD-1 Inhibitor Market Size and Growth Rate of Classical Hodgkin Lymphoma from 2016 to 2027

1.4.5 China PD-1 Inhibitor Market Size and Growth Rate of Renal Cell Carcinoma from 2016 to 2027

1.4.6 China PD-1 Inhibitor Market Size and Growth Rate of Other from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of PD-1 Inhibitor by Major Types

3.4.1 Market Size and Growth Rate of Pembrolizumab

3.4.2 Market Size and Growth Rate of Nivolumab

3.4.3 Market Size and Growth Rate of Atezolizumab

3.4.4 Market Size and Growth Rate of Durvalumab

3.4.5 Market Size and Growth Rate of Avelumab

3.4.6 Market Size and Growth Rate of Other

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of PD-1 Inhibitor by Major End-Users

4.4.1 Market Size and Growth Rate of PD-1 Inhibitor in Melanoma

4.4.2 Market Size and Growth Rate of PD-1 Inhibitor in Non-small Cell Lung Cancer (NSCLC)

4.4.3 Market Size and Growth Rate of PD-1 Inhibitor in Urothelial Carcinoma

4.4.4 Market Size and Growth Rate of PD-1 Inhibitor in Classical Hodgkin Lymphoma

4.4.5 Market Size and Growth Rate of PD-1 Inhibitor in Renal Cell Carcinoma

4.4.6 Market Size and Growth Rate of PD-1 Inhibitor in Other

5.1 China PD-1 Inhibitor Production Analysis by Regions

5.2 China PD-1 Inhibitor Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China PD-1 Inhibitor Landscape Analysis by Major Types

6.2 North China PD-1 Inhibitor Landscape Analysis by Major End-Users

7.1 Central China PD-1 Inhibitor Landscape Analysis by Major Types

7.2 Central China PD-1 Inhibitor Landscape Analysis by Major End-Users

8.1 South China PD-1 Inhibitor Landscape Analysis by Major Types

8.2 South China PD-1 Inhibitor Landscape Analysis by Major End-Users

9.1 East China PD-1 Inhibitor Landscape Analysis by Major Types

9.2 East China PD-1 Inhibitor Landscape Analysis by Major End-Users

10.1 Northeast China PD-1 Inhibitor Landscape Analysis by Major Types

10.2 Northeast China PD-1 Inhibitor Landscape Analysis by Major End-Users

11.1 Southwest China PD-1 Inhibitor Landscape Analysis by Major Types

11.2 Southwest China PD-1 Inhibitor Landscape Analysis by Major End-Users

12.1 Northwest China PD-1 Inhibitor Landscape Analysis by Major Types

12.2 Northwest China PD-1 Inhibitor Landscape Analysis by Major End-Users

13.1 Genentech (Roche)

13.2 Onxeo

13.3 Taiwan Liposome Company

13.4 Tiziana Life Sciences

13.5 Sumitomo Dainippon Pharma

13.6 AstraZeneca

13.7 Merck

13.8 Pfizer

13.9 Novartis

Figure Product Picture

Figure China PD-1 Inhibitor Market Size and Growth Rate of Pembrolizumab from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Nivolumab from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Atezolizumab from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Durvalumab from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Avelumab from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Other from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Melanoma from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Non-small Cell Lung Cancer (NSCLC) from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Urothelial Carcinoma from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Classical Hodgkin Lymphoma from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Renal Cell Carcinoma from 2016 to 2027

Figure China PD-1 Inhibitor Market Size and Growth Rate of Other from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China PD-1 Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China PD-1 Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China PD-1 Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China PD-1 Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China PD-1 Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China PD-1 Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China PD-1 Inhibitor Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of PD-1 Inhibitor Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of PD-1 Inhibitor

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of PD-1 Inhibitor by Different Types from 2016 to 2027

Table Consumption Share of PD-1 Inhibitor by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of Pembrolizumab

Figure Market Size and Growth Rate of Nivolumab

Figure Market Size and Growth Rate of Atezolizumab

Figure Market Size and Growth Rate of Durvalumab

Figure Market Size and Growth Rate of Avelumab

Figure Market Size and Growth Rate of Other

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of PD-1 Inhibitor by Different End-Users from 2016 to 2027

Table Consumption Share of PD-1 Inhibitor by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Melanoma

Figure Market Size and Growth Rate of Non-small Cell Lung Cancer (NSCLC)

Figure Market Size and Growth Rate of Urothelial Carcinoma

Figure Market Size and Growth Rate of Classical Hodgkin Lymphoma

Figure Market Size and Growth Rate of Renal Cell Carcinoma

Figure Market Size and Growth Rate of Other

Table China PD-1 Inhibitor Production by Regions

Table China PD-1 Inhibitor Production Share by Regions

Figure China PD-1 Inhibitor Production Share by Regions in 2016

Figure China PD-1 Inhibitor Production Share by Regions in 2021

Figure China PD-1 Inhibitor Production Share by Regions in 2027

Table China PD-1 Inhibitor Consumption by Regions

Table China PD-1 Inhibitor Consumption Share by Regions

Figure China PD-1 Inhibitor Consumption Share by Regions in 2016

Figure China PD-1 Inhibitor Consumption Share by Regions in 2021

Figure China PD-1 Inhibitor Consumption Share by Regions in 2027

Table North China PD-1 Inhibitor Consumption by Types from 2016 to 2027

Table North China PD-1 Inhibitor Consumption Share by Types from 2016 to 2027

Figure North China PD-1 Inhibitor Consumption Share by Types in 2016

Figure North China PD-1 Inhibitor Consumption Share by Types in 2021

Figure North China PD-1 Inhibitor Consumption Share by Types in 2027

Table North China PD-1 Inhibitor Consumption by End-Users from 2016 to 2027

Table North China PD-1 Inhibitor Consumption Share by End-Users from 2016 to 2027

Figure North China PD-1 Inhibitor Consumption Share by End-Users in 2016

Figure North China PD-1 Inhibitor Consumption Share by End-Users in 2021

Figure North China PD-1 Inhibitor Consumption Share by End-Users in 2027

Table Central China PD-1 Inhibitor Consumption by Types from 2016 to 2027

Table Central China PD-1 Inhibitor Consumption Share by Types from 2016 to 2027

Figure Central China PD-1 Inhibitor Consumption Share by Types in 2016

Figure Central China PD-1 Inhibitor Consumption Share by Types in 2021

Figure Central China PD-1 Inhibitor Consumption Share by Types in 2027

Table Central China PD-1 Inhibitor Consumption by End-Users from 2016 to 2027

Table Central China PD-1 Inhibitor Consumption Share by End-Users from 2016 to 2027

Figure Central China PD-1 Inhibitor Consumption Share by End-Users in 2016

Figure Central China PD-1 Inhibitor Consumption Share by End-Users in 2021

Figure Central China PD-1 Inhibitor Consumption Share by End-Users in 2027

Table South China PD-1 Inhibitor Consumption by Types from 2016 to 2027

Table South China PD-1 Inhibitor Consumption Share by Types from 2016 to 2027

Figure South China PD-1 Inhibitor Consumption Share by Types in 2016

Figure South China PD-1 Inhibitor Consumption Share by Types in 2021

Figure South China PD-1 Inhibitor Consumption Share by Types in 2027

Table South China PD-1 Inhibitor Consumption by End-Users from 2016 to 2027

Table South China PD-1 Inhibitor Consumption Share by End-Users from 2016 to 2027

Figure South China PD-1 Inhibitor Consumption Share by End-Users in 2016

Figure South China PD-1 Inhibitor Consumption Share by End-Users in 2021

Figure South China PD-1 Inhibitor Consumption Share by End-Users in 2027

Table East China PD-1 Inhibitor Consumption by Types from 2016 to 2027

Table East China PD-1 Inhibitor Consumption Share by Types from 2016 to 2027

Figure East China PD-1 Inhibitor Consumption Share by Types in 2016

Figure East China PD-1 Inhibitor Consumption Share by Types in 2021

Figure East China PD-1 Inhibitor Consumption Share by Types in 2027

Table East China PD-1 Inhibitor Consumption by End-Users from 2016 to 2027

Table East China PD-1 Inhibitor Consumption Share by End-Users from 2016 to 2027

Figure East China PD-1 Inhibitor Consumption Share by End-Users in 2016

Figure East China PD-1 Inhibitor Consumption Share by End-Users in 2021

Figure East China PD-1 Inhibitor Consumption Share by End-Users in 2027

Table Northeast China PD-1 Inhibitor Consumption by Types from 2016 to 2027

Table Northeast China PD-1 Inhibitor Consumption Share by Types from 2016 to 2027

Figure Northeast China PD-1 Inhibitor Consumption Share by Types in 2016

Figure Northeast China PD-1 Inhibitor Consumption Share by Types in 2021

Figure Northeast China PD-1 Inhibitor Consumption Share by Types in 2027

Table Northeast China PD-1 Inhibitor Consumption by End-Users from 2016 to 2027

Table Northeast China PD-1 Inhibitor Consumption Share by End-Users from 2016 to 2027

Figure Northeast China PD-1 Inhibitor Consumption Share by End-Users in 2016

Figure Northeast China PD-1 Inhibitor Consumption Share by End-Users in 2021

Figure Northeast China PD-1 Inhibitor Consumption Share by End-Users in 2027

Table Southwest China PD-1 Inhibitor Consumption by Types from 2016 to 2027

Table Southwest China PD-1 Inhibitor Consumption Share by Types from 2016 to 2027

Figure Southwest China PD-1 Inhibitor Consumption Share by Types in 2016

Figure Southwest China PD-1 Inhibitor Consumption Share by Types in 2021

Figure Southwest China PD-1 Inhibitor Consumption Share by Types in 2027

Table Southwest China PD-1 Inhibitor Consumption by End-Users from 2016 to 2027

Table Southwest China PD-1 Inhibitor Consumption Share by End-Users from 2016 to 2027

Figure Southwest China PD-1 Inhibitor Consumption Share by End-Users in 2016

Figure Southwest China PD-1 Inhibitor Consumption Share by End-Users in 2021

Figure Southwest China PD-1 Inhibitor Consumption Share by End-Users in 2027

Table Northwest China PD-1 Inhibitor Consumption by Types from 2016 to 2027

Table Northwest China PD-1 Inhibitor Consumption Share by Types from 2016 to 2027

Figure Northwest China PD-1 Inhibitor Consumption Share by Types in 2016

Figure Northwest China PD-1 Inhibitor Consumption Share by Types in 2021

Figure Northwest China PD-1 Inhibitor Consumption Share by Types in 2027

Table Northwest China PD-1 Inhibitor Consumption by End-Users from 2016 to 2027

Table Northwest China PD-1 Inhibitor Consumption Share by End-Users from 2016 to 2027

Figure Northwest China PD-1 Inhibitor Consumption Share by End-Users in 2016

Figure Northwest China PD-1 Inhibitor Consumption Share by End-Users in 2021

Figure Northwest China PD-1 Inhibitor Consumption Share by End-Users in 2027

Table Company Profile and Development Status of Genentech (Roche)

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche)

Figure Sales and Growth Rate Analysis of Genentech (Roche)

Figure Revenue and Market Share Analysis of Genentech (Roche)

Table Product and Service Introduction of Genentech (Roche)

Table Company Profile and Development Status of Onxeo

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Onxeo

Figure Sales and Growth Rate Analysis of Onxeo

Figure Revenue and Market Share Analysis of Onxeo

Table Product and Service Introduction of Onxeo

Table Company Profile and Development Status of Taiwan Liposome Company

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taiwan Liposome Company

Figure Sales and Growth Rate Analysis of Taiwan Liposome Company

Figure Revenue and Market Share Analysis of Taiwan Liposome Company

Table Product and Service Introduction of Taiwan Liposome Company

Table Company Profile and Development Status of Tiziana Life Sciences

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiziana Life Sciences

Figure Sales and Growth Rate Analysis of Tiziana Life Sciences

Figure Revenue and Market Share Analysis of Tiziana Life Sciences

Table Product and Service Introduction of Tiziana Life Sciences

Table Company Profile and Development Status of Sumitomo Dainippon Pharma

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma

Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma

Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma

Table Product and Service Introduction of Sumitomo Dainippon Pharma

Table Company Profile and Development Status of AstraZeneca

Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

Figure Sales and Growth Rate Analysis of AstraZeneca

Figure Revenue and Market Share Analysis of AstraZeneca

Table Product and Service Introduction of AstraZeneca

Table Company Profile and Development Status of Merck

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

Figure Sales and Growth Rate Analysis of Merck

Figure Revenue and Market Share Analysis of Merck

Table Product and Service Introduction of Merck

Table Company Profile and Development Status of Pfizer

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

Figure Sales and Growth Rate Analysis of Pfizer

Figure Revenue and Market Share Analysis of Pfizer

Table Product and Service Introduction of Pfizer

Table Company Profile and Development Status of Novartis

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

Figure Sales and Growth Rate Analysis of Novartis

Figure Revenue and Market Share Analysis of Novartis

Table Product and Service Introduction of Novartis